4,138 followers
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody https://t.co/TwFYpWYvQ7
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody https://t.co/TwFYpWYvQ7
RT @ODA0324: 早期アルツハイマー病対象に抗アミロイドβプロトフィブリル抗体「レカネマブ」を投与した試験。結果、主要評価項目は未達成。にも関わらず、製薬会社は米国FDAに段階的申請を開始したとの報道。どうなってしまうのか。https://t.co/sMkkV3tNbj…
@DanClintonRN Oh, also, the 161 patients under lecanemab 10mg/kg bi-weekly from the phase 2 RCT https://t.co/56SLJ8YMpk
@emmakstapp @ProfRobHoward And here is the “core study.” https://t.co/lR90wbt0UD